“…Sixteen fusion partners have been already isolated and sequenced. These include AF4 (4q21), AF9 (9p22), ENL (19p13.3), ELL (19p13.1), EEN (19p13), AF6 (6q27), EPS15 (1p32), AFX (Xq13), AF10 (10p12), AF17 (17q21), CBP (16p13), MSF (17q25), p300 (22q13), AF6q21 (6q21), ABI1 (10p12), and hCDCrel (22q11.2) (Gu et al, 1992;Nakamura et al, 1993;Rubnitz et al, 1994;Thirman et al, 1994;So et al, 1997;Prasad et al, 1993Prasad et al, , 1994Bernard et al, 1994;Parry et al, 1994;Chaplin et al, 1995;Sobulo et al, 1997;Osaka et al, 1999;Ida et al, 1997;Hillion et al, 1997;Taki et al, 1998;Megonigal et al, 1998). The large number of seemingly unrelated fusion partners initially gave rise to the speculation that the fusion of MLL itself is the essential event leading to leukemia by a loss of function mechanism.…”